Bioventus Inc. (BVS) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $51.24M | +23.2% |
| 2024 | $41.58M | +12.5% |
| 2023 | $36.96M | +22.5% |
| 2022 | $30.19M | -31.3% |
| 2021 | $43.93M | -49.4% |
| 2020 | $86.84M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $51.24M | +23.2% |
| 2024 | $41.58M | +12.5% |
| 2023 | $36.96M | +22.5% |
| 2022 | $30.19M | -31.3% |
| 2021 | $43.93M | -49.4% |
| 2020 | $86.84M | — |